AZN vs LLY
AstraZeneca PLC · Eli Lilly and Company
Relative return (rebased to 100)
Key stats
| Metric | AZN | LLY |
|---|---|---|
| Price | $166.14 | $1,152.44 |
| Market Cap | $257.52B | $1.08T |
| P/E | 25.19 | 52.56 |
| P/B | 5.29 | 32.02 |
| P/S | 4.38 | 16.64 |
| ROE | 21.0% | 60.9% |
| Net Margin | 17.4% | 31.7% |
| Gross Margin | 81.9% | — |
| Revenue Growth | 8.6% | 44.7% |
| Dividend Yield | 1.88% | 0.54% |
| EPS | $6.60 | $21.93 |
Metrics from owned fundamentals, updated daily. Highlighted values are the more favorable of the two.